Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 3/20 | 0.81 |
| ▸ | CHRM2 | P08172 | 13/20 | 0.53 |
| ▸ | BCHE | P06276 | 5/20 | 0.53 |
| ▸ | ACHE | P22303 | 5/20 | 0.53 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.53 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.53 |
| ▸ | GRIN1 | Q05586 | 4/20 | 0.53 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.53 |
| ▸ | RECQL | P46063 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | THPO | P40225 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8852020 | 0.91 | SLC2A1 (0.75) | SLC2A1CHRM2BCHEACHECHRM4 | |
| SCHEMBL8851441 | 0.84 | SLC2A1 (0.69) | SLC2A1CHRM2GRIN1GRIN2AMEN1 | |
| SCHEMBL3265276 | 0.83 | SLC2A1 (0.57) | SLC2A1CHRM2GRIN1GRIN2A | |
| SCHEMBL4289756 | 0.81 | SLC2A1 (0.55) | SLC2A1CHRM2BCHEACHECHRM4 | |
| SCHEMBL3268488 | 0.81 | CHRM2 (0.78) | CHRM2BCHEACHECHRM4CHRM5 | |
| SCHEMBL1254100 | 0.77 | SLC2A1 (0.64) | SLC2A1MEN1KMT2AATMMAPT | |
| SCHEMBL3265306 | 0.77 | KMT2A (0.67) | SLC2A1TSHRMEN1KMT2APOLB | |
| SCHEMBL12776653 | 0.76 | SLC2A1 (0.62) | SLC2A1TSHRMEN1KMT2AATM | |
| SCHEMBL22094621 | 0.75 | SLC2A1 (0.48) | SLC2A1CHRM2BCHEACHECHRM4 | |
| SCHEMBL31308887 | 0.75 | SLC2A1 (0.48) | SLC2A1CHRM2BCHEACHECHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004262-A1 | PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE | ORYZON GENOMICS, S.A. (ES) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004262-A1 | PHENYLCYCLOPROPYLAMINE DERIVATIVES AND THEIR MEDICAL USE | PNMT, ABCB1, SNCA | SLC2A1 1019/4885CHRM2 201/4885BCHE 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.